Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol

6Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Septic shock still has a high mortality rate which has not hinted at decreasing in recent years. Unfortunately, randomized trials failed mainly because the septic patient was considered as a homogeneous entity. All this creates a sort of therapeutic impotence in everyday clinical practice in treating patients with septic shock. The need to customize therapy on each patient with sepsis has now become an established necessity. In this scenario, adjuvant therapies can help if interpreted as modulators of the immune system. Indeed, the host's immune response differs from patient to patient based on the virulence of the pathogen, comorbidity, infection site, and prolonged hospitalization. In this review, we summarize the rationale for using immunoglobulins as an adjunctive treatment. Furthermore, we would like to suggest a possible protocol to personalize treatment in the different clinical scenarios of the host's response to serious infectious events.

References Powered by Scopus

The third international consensus definitions for sepsis and septic shock (sepsis-3)

18479Citations
N/AReaders
Get full text

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

4886Citations
N/AReaders
Get full text

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation: On behalf of the scientific subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haematostasis (ISTH)

1846Citations
N/AReaders
Get full text

Cited by Powered by Scopus

During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant

9Citations
N/AReaders
Get full text

Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial

8Citations
N/AReaders
Get full text

The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Busani, S., Roat, E., Tosi, M., Biagioni, E., Coloretti, I., Meschiari, M., … Girardis, M. (2021, February 18). Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2021.616511

Readers over time

‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

33%

PhD / Post grad / Masters / Doc 1

33%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

83%

Pharmacology, Toxicology and Pharmaceut... 1

17%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 1

Save time finding and organizing research with Mendeley

Sign up for free
0